Navigation Links
Pacira Pharmaceuticals, Inc. Reports First Quarter 2011 Financial Results
Date:5/11/2011

b>Full Year 2011 Financial GuidancePacira is reiterating its 2011 financial guidance and currently expects to achieve revenue in the range of $14 and $16 million for the full-year ending December 31, 2011.  This revenue expectation excludes the impact of potential sales of EXPAREL should it receive approval from the FDA in the third quarter of 2011 and be commercialized by Pacira in the fourth quarter of 2011.  The company also expects cash burn, excluding the impact of any future partnerships, asset monetizations or other cash generating activities unrelated to its current operations, to be approximately $30 million cumulatively through the third quarter of 2011, and, approximately $25 million in the fourth quarter of 2011.  These cash burn expectations are based upon the assumption that EXPAREL will receive FDA approval in the third quarter of 2011, and that Pacira will commercialize EXPAREL in the fourth quarter of 2011, and include a $10 million milestone payment in the fourth quarter of 2011 to Skye Pharmaceuticals due upon the first commercial sale of EXPAREL.  

Recent Developments

  • Entered into a Partner Program Agreement with Novo Nordisk:  In January 2011 Pacira entered into an agreement with Novo Nordisk A/S (Novo), pursuant to which Pacira granted Novo Nordisk rights to develop, manufacture and commercialize formulations of a Novo Nordisk proprietary drug using Pacira's DepoFoam® drug delivery technology. Pacira received an upfront license fee of $1.5 million and is entitled to receive up to $24 million in development-based milestone payments and up to an additional $20 million in sales-based milestone payments. Pacira is also entitled to single-digit royalties on sales of any Novo Nordisk product resulting from this development agreement.
  • Presented new Phase 3 EXPAREL data at two medical meetings: In January 2011 data from Pacira's Phase 3 multicenter, randomized, double-bli
    '/>"/>

  • SOURCE Pacira Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Pacira Pharmaceuticals, Inc. Announces EXPAREL™ Data Presentations
    2. Pacira Pharmaceuticals, Inc. Announces Timing for First Quarter 2011 Financial Results Webcast and Conference Call
    3. Pacira Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
    4. Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results
    5. Pacira Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
    6. Pacira Pharmaceuticals EXPAREL™ Data to be Featured at 2011 ASCPT 112th Annual Meeting
    7. Pacira Pharmaceuticals Highlights Additional Safety Data on EXPAREL™ for Postsurgical Pain Relief at 2011 American Academy of Orthopaedic Surgeons Annual Meeting
    8. Pacira Pharmaceuticals, Inc. Announces Pricing of Its Initial Public Offering
    9. Pacira Pharmaceuticals Presents New Data from EXPAREL Phase 3 Study at Orthopaedic Research Societys 57th Annual Meeting
    10. Pacira Pharmaceuticals Announces FDA Acceptance of EXPAREL™ New Drug Application for Pain Management
    11. Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/26/2014)... Oregon , November 26, 2014 ... fascia of the organ protrudes through the wall of a ... muscle area at birth are some of the causes of ... umbilical, hiatal, femoral, and incisional. An inguinal hernia is when ... An umbilical hernia is found in the area of the ...
    (Date:11/26/2014)... , Nov. 26, 2014  Aridis Pharmaceuticals, ... produce novel therapies for infectious diseases, announced today ... an internationally recognized key opinion leader in the ... scientific advisory board. Founder and Chief ... "We believe Dr. Opal,s extensive experience investigating bacterial ...
    (Date:11/26/2014)... 2014 According to the ... Source (Electric, Battery, Pneumatic), by Product (Drill, Saw, ... by Application (Orthopedic, ENT, Oral, Thoracic, Neurology) - ... Powered Surgical Instruments Market is estimated to be ... and is expected to grow at a moderate ...
    Breaking Medicine Technology:Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 2Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 3Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 4Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 4
    ... , , , , MINNEAPOLIS, Jan. 11 ... marketer of state-of-the-art cardiac surgery products and services today announced ... advance of a presentation by ATS Medical,s President and Chief ... Healthcare Conference on Wednesday, January 13, 2010, in San Francisco, ...
    ... Jan. 11, 2010 Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ... the Company to address the dual epidemics of diabetes and ... the year and place the Company on the path to ... presented by Daniel M. Bradbury, president and chief executive officer, ...
    Cached Medicine Technology:ATS Medical Announces Preliminary Fourth Quarter 2009 Results 2ATS Medical Announces Preliminary Fourth Quarter 2009 Results 3ATS Medical Announces Preliminary Fourth Quarter 2009 Results 4Amylin Highlights 2010 Corporate Priorities at J.P. Morgan Healthcare Conference 2Amylin Highlights 2010 Corporate Priorities at J.P. Morgan Healthcare Conference 3
    (Date:11/27/2014)... VogueQueen.com is making every effort to ... the world. As the premier online supplier of elegant ... to release a huge selection of sexy prom dresses ... is also providing many beautiful styles in its product ... at discounted prices. , “VogueQueen.com hopes to provide a ...
    (Date:11/27/2014)... Albany, IN (PRWEB) November 27, 2014 Dr. ... implant clinic, has a few oral health tips before ... Receveur, who offers Louisville and New Albany affordable cosmetic ... of foods high in starch and sugar. While the staff ... has some helpful tips for how patients can enjoy a ...
    (Date:11/27/2014)... to help with chores while they are home from school, ... self-esteem, and above all, helps parents maintain a somewhat tidy ... do you encourage your children to want to help? Is ... Development Journal, there is. The study found that adults’ language ... lend a hand. , The study found that using ...
    (Date:11/27/2014)... Ethane Web Technologies, which is an internationally ... management service. , The company has designed the ... of internet marketing and algorithms of major search engines ... Technologies does not work with the same strategy on ... reach a conclusion what will work for the project ...
    (Date:11/27/2014)... Lintelus, Inc., an event software ... increasing audience engagement at Convergence Summit 11th Annual ... includes a multitude of interactive features designed to ... interactive multi-screen environment. Best of all, attendees can ... time on their own device. , Approximately 200 ...
    Breaking Medicine News(10 mins):Health News:A New Collection of Sexy Prom Dresses Has Been Released by the Reliable Online Supplier VogueQueen.com 2Health News:New Albany Dental Practice Offers Oral Health Tips For Thanksgiving 2Health News:New Albany Dental Practice Offers Oral Health Tips For Thanksgiving 3Health News:New Albany Dental Practice Offers Oral Health Tips For Thanksgiving 4Health News:Ethane Web Technologies Announces Online Reputation Management Service 2Health News:Lintelus Showcases its Feature-Rich Presentation Technology Solution at Convergence Summit’s Annual Event in London 2
    ... antibody (mAb) product has entered a phase I clinical ... study in the US. , ,Crucell has ... prophylaxis of rabies, using Crucell’s MAbstract and Crucell’s PER.C6 ... to the initial phase I study that is currently ...
    ... Hyderabad-based Biological E. Ltd. announced that they have ... II clinical trial for Intercell’s novel Japanese Encephalitis ... controlled study aims to demonstrate the dose, safety ... a locally produced mouse-brain Japanese Encephalitis vaccine. ...
    ... question in hair salons but today it's easy to get lost in ... ,'Styling Cream', 'Matt Paste' or even 'Jelly Gel' compete with each ... hair just right. ,Right now the hot favourites on the ... gel. ,They give hair body while remaining flexible at the ...
    ... by young adults significantly boost their risk of stroke, with ... a research. ,In the study, available online in the ... 8,300 stroke patients – ranging in age from 18 to ... 2000 through 2003. ,An analysis of risk ...
    ... Every year around the world nearly one million children ... pneumonia and other pneumococcal diseases//. ,Considering ... recommended the inclusion of the 7-valet vaccine that addresses ... programs of developing countries. ,Pneumococcal diseases, which ...
    ... with early-stage breast cancer who are treated with ... rate than patients who receive only tamoxifen//. But ... stop the ovaries from functioning—did not show any ... ,Survival rates improve for ...
    Cached Medicine News:Health News:Crucell's Rabies MAb Enters Phase I Trial in India 2Health News:Gels, Wax or Paste: New Styling Products for Men's Hair 2Health News:Amphetamine, Cocaine Use Increase Risk of Stroke in Young Adults 2Health News:Combining Therapies can Improve Survival for Early-stage Breast Cancer Patients 2
    ... Automated Microplate Washer is ... any laboratory. The unique ... a precise height adjustment ... digitally controlled aspiration- and ...
    ... washer MP-1200 is a compact and ... Its internal micropumps enable the system ... from all types of microtiter well. ... washed in rows of 8 wells ...
    High-quality microplate washer with robot compatibility. It offers additional washing capacity, first-rate efficiency in high-throughput and research applications....
    MultiWash Advantage is a versatile microplate washer engineered for reliability. It is designed for lab environments to help streamline their daily processes....
    Medicine Products: